Clinical Trials | November 11, 2021
LifeCell Diagnostics expands newborn screening portfolio
LSDCheck is CE-IVD approved LCMSMS-based testing kit for LSD in newborns
LSDCheck is CE-IVD approved LCMSMS-based testing kit for LSD in newborns
In India, MSD has signed non-exclusive licensing agreements with eight pharma companies.
The Research Services and Biosimilars business segments reported a growth of 17% and 10%, respectively
Express Scripts, a leading pharmacy benefit management organization, will list Viatris labelled biosimilar insulin Glargine as a preferred insulin brand on its National Preferred Formulary (NPF)
The listings aim to address global health priorities, identifying the medicines that provide the greatest benefits, and which should be available and affordable for all
The government plans to enrol over 50 crore people and empanel more hospitals under the scheme. The scheme provides a cover of Rs 5 lakh per family per year
By 2022, 150,000 primary health care centres would be in place in rural as well as urban areas
Subscribe To Our Newsletter & Stay Updated
